Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 6, 2021; 9(19): 5028-5036
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5028
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5028
Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral artery atherosclerosis obliterative cerebral infarction
Xi-Feng Wang, Ming Wang, Gang Li, Xue-Yu Xu, Wei Shen, Jing Liu, Shuang-Shuang Xiao, Jiang-Hong Zhou, Department of Neurology, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430033, Hubei Province, China
Author contributions: Wang XF, Wang M and Li G designed the research; Xu XY, Shen W and Liu J performed the research; Liu J and Xiao SS contributed new reagents/analytic tools; Wang XF analyzed the data; Wang XF and Zhou JH wrote the paper.
Institutional review board statement: The study was reviewed and approved by the Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology Institutional Review Board.
Informed consent statement: Informed written consent was obtained from the patients.
Conflict-of-interest statement: No one at any time received payment or services from a third party (government, commercial, private foundation, etc .) for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis). No one has financial relationships (regardless of amount of compensation) with entities as described in the instructions during the 36 mo prior to publication.
STROBE statement: The authors have read the STROBE statement, and the manuscript was prepared and revised according to the STROBE statement.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at 815107426@qq.com.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jiang-Hong Zhou, MSc, Professor, Department of Neurology, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 76 Jiefang Avenue, Qiaokou District, Wuhan 430033, Hubei Province, China.
Received: March 2, 2021
Peer-review started: March 2, 2021
First decision: April 4, 2021
Revised: April 10, 2021
Accepted: April 20, 2021
Article in press: April 20, 2021
Published online: July 6, 2021
Processing time: 113 Days and 22.5 Hours
Peer-review started: March 2, 2021
First decision: April 4, 2021
Revised: April 10, 2021
Accepted: April 20, 2021
Article in press: April 20, 2021
Published online: July 6, 2021
Processing time: 113 Days and 22.5 Hours
Core Tip
Core Tip: There are currently only a few reports on the differences in endovascular treatment for different etiological classifications, especially in the anterior cranial circulation, aorta atherosclerotic stenosis, and acute thrombosis. There are no relevant reports on the use of Solitaire stent mechanical thrombectomy or stent release angioplasty when used above level 2b/3 (modified thrombolysis in cerebral infarction).